Literature DB >> 17273881

Seroprevalence of vaccine preventable and blood transmissible viral infections (measles, mumps, rubella, polio, HBV, HCV and HIV) in medical students.

Sabine Wicker1, Holger F Rabenau, René Gottschalk, Hans Wilhelm Doerr, Regina Allwinn.   

Abstract

In the course of clinical training medical students are in particular exposed to infectious diseases. Therefore, the present study was performed to investigate the immunity status of 223 medical students in their first clinical semester to job-related diseases. Specific serological antibody testing of hepatitis B-virus (HBV), hepatitis C-virus (HCV), human immunodeficiency virus (HIV), varicella zoster- (VZV), measles-, mumps-, rubella and polioviruses' type 1, 2 and 3 were performed. The results yielded, that 69.5% of the students had an anti-HBs-level > or =10 IU/l and 54.7% > or =100 IU/l. Neither HCV infection nor HIV infection were found, but one student showed an active HBV infection. Virus specific immunity rates were found in 91.5% for measles, 80.3% for mumps, 90.1% for rubella and 96.9% for varicella. Furthermore the medical students demonstrated neutralizing antibodies to polioviruses: 95.1% (type 1), 96.9% (type 2) and 70% (type 3). 68.2% had antibodies (titer 1:> or =10) against all three virus types. The partly significant gaps of immunity in the students need to be closed prior to the first contact with patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17273881     DOI: 10.1007/s00430-007-0036-3

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  17 in total

1.  Protection against vaccine-preventable diseases in medical students.

Authors:  Gurli Baer; Jan Bonhoeffer; Urs B Schaad; Ulrich Heininger
Journal:  Pediatr Infect Dis J       Date:  2003-04       Impact factor: 2.129

2.  [Immunization against poliomyelitis--can it soon be dispensed with in Germany?].

Authors:  R Allwinn; H W Doerr
Journal:  Dtsch Med Wochenschr       Date:  2003-08-15       Impact factor: 0.628

3.  The effectiveness of the mumps component of the MMR vaccine: a case control study.

Authors:  Richard Harling; Joanne M White; Mary E Ramsay; Karen F Macsween; Corry van den Bosch
Journal:  Vaccine       Date:  2005-07-01       Impact factor: 3.641

4.  [What do medical students know about their vaccination status and how effective is their vaccine protection?].

Authors:  H Wallaschofski; H Drexler; K Schmid
Journal:  Dtsch Med Wochenschr       Date:  2005-06-10       Impact factor: 0.628

5.  [German Health survey 1997/98: immune status against poliomyelitis].

Authors:  S Diedrich; H Claus; W Thierfelder; B M Bellach; E Schreier
Journal:  Dtsch Med Wochenschr       Date:  2000-05-12       Impact factor: 0.628

6.  Two outbreaks of measles in Germany 2005.

Authors:  A Siedler; A Tischer; A Mankertz; S Santibanez
Journal:  Euro Surveill       Date:  2006

7.  Quantitative detection of neutralizing antibodies against polioviruses and non-polio enteroviruses (NPEV) using an automated microneutralization assay: a seroepidemiologic survey.

Authors:  B Weber; H Rabenau; J Cinatl; G Maass; H W Doerr
Journal:  Zentralbl Bakteriol       Date:  1994-03

8.  Seroprevalence and immunization history of selected vaccine preventable diseases in medical students.

Authors:  Gurli Baer; Jan Bonhoeffer; Urs B Schaad; Ulrich Heininger
Journal:  Vaccine       Date:  2005-03-14       Impact factor: 3.641

9.  Epidemiological analysis of immunity to poliovirus after termination of an era of vaccination with OPV in Germany. An analysis of the German Association Against Viral Diseases (DVV).

Authors:  S Franck; R Allwinn; H F Rabenau; H W Doerr
Journal:  Zentralbl Bakteriol       Date:  1999-10

10.  [Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox].

Authors:  S Buxbaum; H W Doerr; R Allwinn
Journal:  Dtsch Med Wochenschr       Date:  2001-11-16       Impact factor: 0.628

View more
  24 in total

Review 1.  Vaccination recommendations for Germany.

Authors:  Miriam Wiese-Posselt; Christine Tertilt; Fred Zepp
Journal:  Dtsch Arztebl Int       Date:  2011-11-04       Impact factor: 5.594

2.  Monitoring prevalence of varicella-zoster virus clades in Germany.

Authors:  A Sauerbrei; J Stefanski; A Philipps; A Krumbholz; R Zell; P Wutzler
Journal:  Med Microbiol Immunol       Date:  2010-10-31       Impact factor: 3.402

3.  High seroprevalence of varicella, measles, mumps, rubella and pertussis antibodies in first-grade medical students.

Authors:  Maja Socan; Natasa Berginc
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 4.  [Vaccination in adults].

Authors:  D M Kieninger-Baum; F Zepp
Journal:  Internist (Berl)       Date:  2011-03       Impact factor: 0.743

5.  Assessment of mumps virus-specific antibodies by different serological assays: which test correlates best with mumps immunity?

Authors:  R Allwinn; B Zeidler; K Steinhagen; E Rohwäder; S Wicker; H F Rabenau; H W Doerr
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-01       Impact factor: 3.267

Review 6.  Preventing vertical virus infections: the role of serologic screening of pregnant women.

Authors:  Annemarie Berger; Hans Wilhelm Doerr
Journal:  Med Microbiol Immunol       Date:  2018-07-03       Impact factor: 3.402

Review 7.  Vaccination against infectious diseases: what is promising?

Authors:  Hans Wilhelm Doerr; Annemarie Berger
Journal:  Med Microbiol Immunol       Date:  2014-07-27       Impact factor: 3.402

Review 8.  A global perspective of vaccination of healthcare personnel against measles: systematic review.

Authors:  Amy Parker Fiebelkorn; Jane F Seward; Walter A Orenstein
Journal:  Vaccine       Date:  2013-11-24       Impact factor: 3.641

9.  Regional spread of HIV-1 M subtype B in middle-aged patients by random env-C2V4 region sequencing.

Authors:  Martin Stürmer; Katrin Zimmermann; Carlos Fritzsche; Emil Reisinger; Gottfried Doelken; Annemarie Berger; Hans W Doerr; Josef Eberle; Lutz G Gürtler
Journal:  Med Microbiol Immunol       Date:  2010-03-09       Impact factor: 3.402

10.  Cross-clade neutralizing antibodies against HIV-1 induced in rabbits by focusing the immune response on a neutralizing epitope.

Authors:  Susan Zolla-Pazner; Sandra Cohen; Abraham Pinter; Chavdar Krachmarov; Terri Wrin; Shixia Wang; Shan Lu
Journal:  Virology       Date:  2009-07-26       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.